Literature DB >> 12638943

Pamidronate treatment of severe osteogenesis imperfecta in a newborn infant.

Y H Chien1, S Y Chu, C C Hsu, W L Hwu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12638943     DOI： 10.1023/a:1022099425316

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  4 in total

Review 1.  Skeletal dysplasias.

Authors:  Deborah Krakow
Journal:  Clin Perinatol       Date:  2015-04-08       Impact factor: 3.430

Review 2.  Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritis.

Authors:  J Thornton; D M Ashcroft; M Z Mughal; R A Elliott; T W O'Neill; D Symmons
Journal:  Arch Dis Child       Date:  2006-05-11       Impact factor: 3.791

Review 3.  Comprehensive pain management strategy for infants with moderate to severe osteogenesis imperfecta in the perinatal period.

Authors:  Ricki S Carroll; Perri Donenfeld; Cristina McGreal; Jeanne M Franzone; Richard W Kruse; Catherine Preedy; Joanna Costa; Daniel R Dirnberger; Michael B Bober
Journal:  Paediatr Neonatal Pain       Date:  2021-12-04

4.  Complications of pamidronate therapy in paediatric osteoporosis.

Authors:  Sanjay K Chilbule; Vrisha Madhuri
Journal:  J Child Orthop       Date:  2012-01-29       Impact factor: 1.548
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.